The 50% ethanol extracts from Resina Pini of Pinus sp. (Pinaceae) showed more potent inhibitory activity against testosterone 5α-reductase prepared from rat prostate than those from several medicinal plants used for the treatment of androgen-dependent diseases such as benign prostatic hyperplasia. The fraction responsible for this activity was purified, and the active constituent was isolated and identified as abietic acid, a diterpene resin acid, which exhibited potent testosterone 5α-reductase inhibitory activity. Methyl abietate was substantially inactive against testosterone 5α-reductase, whereas other diterpene resin acids, pimaric acid and neoabietic acid, were as active as abietic acid against testosterone 5α-reductase, indicating that the negatively charged anionic carboxyl group on the molecule is an important structural moiety for the inhibitory activity. These findings suggest that a nonsteroidal anionic diterpene compound of natural origin may have the potential to act as a transition state analogue inhibitor of testosterone 5α-reductase in the treatment of androgendependent diseases.
INTRODUCTION
Testosterone 5α-reductase [reduced nicotinamide adenine dinucleotide phosphate: Δ 4 -3-ketosteroid 5α-oxidoreductase: Enzyme Commission (EC) 1.3.99.5] catalyzes the reductive conversion of testosterone, the major circulating androgen, to 5α-dihydrotestosterone in target tissues such as the prostate gland and nongenital skin. Testosterone 5α-reductase exists at least as type 1 and type 2 isozymes in the human and the rat. 1) It is generally believed that androgen-dependent diseases such as benign prostatic hyperplasia, male pattern baldness, and acne are associated with an overproduction of 5α-dihydrotestosterone in many tissues. 1) Therefore inhibition of this enzymatic conversion represents an important pharmacologic approach to the selective treatment of these androgen-dependent diseases. 2) Most testosterone 5α-reductase inhibitors developed are steroid derivatives, which bind to steroid receptors and are expected to produce various undesirable hormonal effects by acting as agonists or antagonists. 2) Alternatively, phytotherapeutic preparations from many medicinal plant sources have been commonly used for the treatment of such androgen-dependent diseases. 3) In particular, extracts from several types of medicinal plant sources have remarkable blocking effects on testosterone 5α-reductase activity. 3) Moreover, specific nonsteroidal constituents with moderately potent testosterone 5α-reductase inhibitory activity have been isolated from several selected medicinal plant species. [4] [5] [6] [7] [8] [9] [10] In the course of examining the effects of several medicinal plants used as integrated medicines against androgen-dependent diseases on the activity of testosterone 5α-reductase prepared from rat prostate, we found that the 50% ethanol extract of Resina Pini of Pinus sp. (Pinaceae) showed potent inhibitory activity. In the present study, we investigated the active components in the 50% ethanol extract of Resina Pini of Pinus sp. to determine their testosterone 5α-reductase inhibitory activity against androgen-dependent diseases. 
MATERIALS AND METHODS

General Experimental Procedures
Preparation of Extracts and Isolation of Active
Compounds --The dried Resina Pini of Pinus sp. (500 g) was extracted with 50% ethanol (2 l × 2) at room temperature for 3 days. After filtration, the extract was evaporated under reduced pressure and lyophilized to give a 50% ethanol extract (29.2 g). The other medicinal plant species, C. majus, E. hyemale, T. aestivum, P. aviculare, P. cuspidatum, P. multiflorum, and P. cernua, were extracted in a similar manner to afford 50% ethanol extracts, which were used for assay of inhibition against testosterone 5α-reductase. The 50% ethanol extract was partitioned between ethyl acetate and water to give an ethyl acetate-soluble fraction and an aqueous fraction, respectively. The ethyl acetate-soluble fraction was then separated by repeated preparative TLC with the guidance of rat prostate testosterone 5α-reductase inhibitory activity. The active fraction was further purified by recrystallization from ethanol to give the active component, compound 1, as a yellow powder (1.33 g). The powder was determined to contain exclusively compound 1 using an HPLC system with an octadecylsilane (ODS) column and methanol/water/trifluoroacetic acid (80 : 20 : 0.1). Enzymatic Assay --A homogenate of the ventral prostate gland of male Sprague-Dawley rats was prepared, and testosterone 5α-reductase inhibition was measured using the methods previously reported. 5) Both the type 1 and the type 2 isozymes are present in the ventral prostate of the rat. In the assay, since rat prostate extracts were used in a neutral pH buffer, both isozymes were assayed. The ventral prostate glands were excised and minced with a pair of scissors. The 20 w/v% homogenates were prepared with a glass-glass homogenizer in medium A (sucrose 0.32 M, dithiothreitol 0.1 mM, and sodium phosphate 20 mM, pH 6.5). The homogenate was filtered with surgical gauze and then centrifuged at 3000 × g for 10 min. The pellets were suspended in medium A at a protein concentration of 20 mg/ml by triturating sequentially through an 18-gauge and then a 20-gauge needle. To 40 µl of the enzyme suspension, 10 µl of test sample in ethanol or ethanol alone and a mixture containing 0.525 ml of reaction solution consisting of dithiothreitol 1 mM, sodium phosphate 40 mM, pH 6.5, NADPH 5 × 10 −5 M, and [1,2,6,7-3 H]testosterone 2.2 × 10 −9 M were added. The assay mixture was incubated at 37 • C for 30 min. The reaction was stopped by the addition of 1 ml of ethyl acetate, and 50 µl of the upper phase was separated on a silica gel plate in the developing solvent system of ethyl acetate/cyclohexane, 1 : 1. The zones corresponding to the testosterone and the 5α-dihydrotestosterone were cut into fragments. Each fragment was added to 5 ml of Aquasol-2 and counted with a liquid scintillation counter to determine 3 H radioactivity.
The inhibitory activity of each test sample was calculated as follows:
Rate of enzyme reaction (R, %)
Inhibitory activity (%)
Where 
RESULTS AND DISCUSSION
In the course of the search for medicinal plant sources used in several remedies against androgendependent diseases including benign prostatic hyperplasia which have testosterone 5α-reductase inhibitory activity, the 50% ethanol extract of Resina Pini of Pinus sp. showed potent testosterone 5α-reductase inhibitory activity (Table 1) . A 500 µg/ml solution of the dried 50% ethanol extract of Resina Pini of Pinus sp. showed a 78.2% inhibition of the enzyme. The inhibitory activity of the 50% ethanol extract of this crude drug was superior to that of each of several medicinal plant species, C. majus, E. hyemale, T. aestivum, P. aviculare, P. cuspidatum, P. multiflorum, and P. cernua, all of which have been used in phytotherapeutic preparations for the treatment of benign prostatic hyperplasia. When the 50% ethanol extract was partitioned between ethyl acetate and water, the ethyl acetate-soluble portion exhibited inhibition of the enzyme. Further, when the 50% ethanol extract was adjusted to pH 3.0 and pH 9.0 by respective treatment with acid and alkali and then extracted with ethyl acetate, the portion responsible for the inhibition of the enzyme was ex- tractable exclusively with acid treatment. The ethyl acetate-extractable portion was concentrated by repeated extraction with aqueous alkaline solution and an acidified organic phase. The portion was separated by repeated preparative TLC with the guidance of rat prostate testosterone 5α-reductase inhibitory activity, followed by recrystallization and HPLC to give the active component, compound 1. Compound 1 in methanol showed characteristic UV absorption peaks at 241.0 and 242.2 nm (ε 22000, 22000), indicating the existence of the CH 2 =CHCH=CH 2 moiety within the compound. The electron ionization (EI)-MS of the compound showed characteristic fragmentation at m/z 301 (M + , 70%), which can be assigned to the molecular ion corresponding to abietic acid. Compound 1 was finally identified by inspection of 1 H-and 13 C-NMR spectra as a diterpene resin acid, abietic acid (Fig. 1) . 11) Rosin (colophony), Resina Pini of Pinus sp., is the residue left after distilling off the volatile oil from the oleoresin (turpentine) obtained from Pinus sp., Pinus palustris Miller, Pinus pinaster Aiton, Pinus sylvestris Linne, Pinus laricio Poiret, Pinus longifolia Roxburgh, Pinus densiflora Siebold et Zuccarini, and Pinus thunbergii Parlatore. About 90% of the rosin is resin acids, and about 90% of resin acids is abietic acid. Abietic acid is used as an ingredient in pharmaceutic aids and in the manufacture of soaps, waxes, printing inks, paper sizings, etc. Abietic acid is also used to assist the growth of lactic and butyric acid bacteria. The isolated abietic acid was evaluated for the inhibitory activity against rat prostate testosterone 5α-reductase. Abietic acid exhibited inhibitory activity in a dosedependent manner, and showed inhibition of 3.9%, 22.6%, 59.3%, and 95.9% at concentrations of 1, 10, 100, and 1000 µM, respectively (Table 2) . Although abietic acid showed much less potent inhibitory activity than finasteride, the inhibitory activity of the compound was on the same order as that of riboflavin, in which finasteride and riboflavin were used as a steroidal and a nonsteroidal positive control, respectively. 1, 12) Methyl abietate, which is the methyl ester of abietic acid, was substantially inactive against testosterone 5α-reductase, indicating that the carboxyl group in the structure of abietic acid is an important structural moiety for the inhibitory activity. Consistent with this concept, other diterpene resin acids like pimaric acid and neoabietic acid also showed significant inhibitory activity against testosterone 5α-reductase, indicating that the negatively charged anionic carboxyl group on the molecule is the structural determinant for the inhibitory activity. On the basis of the theory of enzyme catalysis, high-energy transition states or intermediates bind more tightly to enzymes than ground-state substrates or products in enzymatic reaction. 13) The proposed mechanism for testosterone 5α-reductase postulates an enolate as a high energy intermediate of the steroid component. 14) During the testosterone 5α-reductase reaction, these anionic resin acid-type inhibitors like abietic acid may represent greatly simplified transition state analogues similar to the enolate intermediate. Steroidal acrylates such as epristeride were designed to mimic the geometry and electrostatic properties of the proposed enolate intermediate. 14) The anionic resin acid-type inhibitors such as abietic acid possess a one-carbon extension in the form of a carboxylic acid at position 4 rather than position 3, suggesting that this element of these compounds approximates more regiospecifically than the steroidal acrylates such as epristeride to the oxyanion at position 3 of the steroidal enolate intermediate (Fig. 1) . 15) Thus it may be necessary to examine the activity of a series of analogues of these anionic diterpene compounds to study the structureactivity relationship for enhancing inhibitory activity. These findings suggest that a nonsteroidal anionic diterpene compound of natural origin may have the potential to act as a transition state analogue inhibitor of testosterone 5α-reductase in the treatment of androgen-dependent diseases. 
